OTC:PVCT | Cash Flow Statement | PROVECTUS BIOPHARMACEUTICALS, INC.

Complete source-backed cash-flow history.

Available history
2002-04-23 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$982,566.00
2026-03-31-$1.29M-$357,565.00$329,872.00
2025-12-31-$1.17M-$869,553.00$1.05M
2025-09-30-$1.31M
2025-06-30-$1.81M
2025-03-31-$1.14M-$1.09M$1.07M
2024-12-31-$2.37M-$912,008.00$788,419.00
2024-09-30-$1.01M
2024-06-30-$846,848.00
2024-03-31-$504,042.00-$1.04M$781,095.00
2023-12-31-$663,413.00-$561,211.00$201,552.00
2023-09-30-$775,839.00
2023-06-30-$835,062.00
2023-03-31-$827,454.00-$624,110.00$515,703.00
2022-12-31-$732,653.00-$754,790.00$474,158.00
2022-09-30-$713,267.00
2022-06-30-$1.08M
2022-03-31-$1.03M-$592,219.00-$33,527.00
2021-12-31-$1.24M$1.62M$1.23M
2021-09-30-$1.05M
2021-06-30-$1.58M
2021-03-31-$1.67M-$1.11M$1.37M
2020-12-31-$1.67M-$957,563.00$69,651.00
2020-09-30-$1.56M
2020-06-30-$1.61M
2020-03-31-$1.83M-$716,322.00$342,640.00
2019-12-31-$1.56M-$1.14M$1.29M
2019-09-30-$1.82M
2019-06-30-$2.18M
2019-03-31-$1.37M-$2.07M$3.81M
2018-12-31-$2.19M-$810,283.00$629,349.00
2018-09-30-$1.61M
2018-06-30-$1.46M
2018-03-31-$2.9M-$1.74M$1.88M
2017-12-31-$2.72M-$2.47M$4,761.00-$4,761.00$2.37M
2017-09-30-$3.11M
2017-06-30-$3.29M
2017-03-31-$4.39M-$3.23M
2016-12-31-$5M-$4.01M
2016-09-30-$5.88M
2016-06-30-$5.04M
2016-03-31-$8.51M-$8.05M
2015-12-31-$9.65M-$4.96M$0.00
2015-09-30-$5.78M
2015-06-30-$4.54M
2015-03-31-$4.53M-$4.19M
2014-12-31$816,240.00-$4.18M$0.00
2014-09-30-$3.75M
2014-06-30-$643,416.00
2014-03-31-$6.67M-$2.85M$3.8M
2013-12-31-$16.6M-$2.18M$0.00$0.00$9.63M
2013-09-30-$4.55M
2013-06-30-$2.38M
2013-03-31-$4.17M-$2.98M$6.07M
2012-12-31-$1.92M-$3.33M$0.00$0.00$2.71M
2012-09-30-$2.35M
2012-06-30-$3.83M
2012-03-31-$4.47M-$2.79M$15,885.00-$15,885.00
2011-12-31-$3.45M-$3.94M$0.00$0.00$836,500.00
2011-09-30-$6.44M
2011-06-30-$4.54M
2011-03-31-$5M-$4.25M$8.56M
2010-12-31-$4.76M-$3.98M$2.02M
2010-09-30-$6.91M
2010-06-30-$3.38M
2002-04-23-$1.32M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$5.43M-$3.33M$3.09M
2024-12-31-$4.73M-$3.28M$2.75M
2023-12-31-$3.1M-$2.57M$2.19M
2022-12-31-$3.55M-$3.04M$1.37M
2021-12-31-$5.54M-$1.01M$4.02M
2020-12-31-$6.68M-$4.09M$3.6M
2019-12-31-$6.92M-$6.19M$6.75M
2018-12-31-$8.15M-$5.2M$5.15M
2017-12-31-$13.52M-$10.35M$30,400.00-$30,400.00$9.32M
2016-12-31-$24.43M-$21.94M
2015-12-31-$24.5M-$17.41M$6,139.00
2014-12-31-$10.24M-$13.85M$70,590.00-$70,590.00
2013-12-31-$27.7M-$9.89M$6,650.00-$6,650.00$24.37M
2012-12-31-$12.57M-$11.26M$15,885.00-$15,885.00$4.79M
2011-12-31-$19.43M-$17.2M$6,147.00-$6,147.00$0.00$16.83M
2010-12-31-$18.55M-$13.73M$18.58M
2009-12-31-$12.32M-$8.6M$5,839.00-$5,839.00$9.04M
2008-12-31-$10.27M
2007-12-31-$10.01M
2006-12-31-$8.87M
2005-12-31-$11.76M
2004-12-31-$4.34M
2003-12-31-$3.16M